Probiotics & Influenza Vaccination Response

Updated 06/21/2024

Status Completed

Clinical Trial Summary

Assess efficacy of oral ingestion of a probiotic product on immune function in a population of healthy adult men and women in a clinical vaccination study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05690373
Study type	Interventional
Source	The Archer-Daniels-Midland Company
Contact
Status	Completed
Phase	N/A
Start date	March 20, 2023
Completion date	June 30, 2023

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT06024096` - Systems Biological Assessment of Statin Effect on Vaccine Responses	Phase 4
	Active, not recruiting	`NCT04953754` - Melatonin and Vaccine Response, Immunity, and Chronobiology Study	N/A
	Completed	`NCT01989533` - Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers	Phase 1
	Active, not recruiting	`NCT05208983` - SafeTy and Efficacy of Preventative CoVID Vaccines
	Recruiting	`NCT04878796` - Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV)
	Completed	`NCT02118402` - Iron and Prebiotics Fortification in Kenyan Infants	N/A
	Recruiting	`NCT04910971` - Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year
	Completed	`NCT05316831` - Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia	Phase 4
	Recruiting	`NCT05518500` - A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults	Phase 4
	Completed	`NCT05924685` - PREPARE-iVAC Trial	Phase 4
	Recruiting	`NCT05801978` - Systems Biological Assessment of the Durability of Vaccine Responses	Phase 4